Determinants of Human Papilloma Vaccine Uptake Among U. S. Military Personnel

Determinants of Human Papilloma Vaccine Uptake Among U. S. Military Personnel

Bibliography

Name: Jennifer Buechel

Rank: CDR

Presenter/Poster:

Year: 2016

Abstract

Abstract Title: Predictors of Human Papillomaviurs (HPV) Vaccine Uptake among U.S. Military Personnel

Author: Jennifer Jean Buechel, PhD, ANP, CCNS, CEN, CCRN, RN

Background: High sexually transmitted infection incidence rates occur in the U.S. military and are one of the leading medical events in the armed forces. The human papillomavirus (HPV) vaccine is recommended for male and females 9 to 26 years of age. Although there are high HPV rates in uniformed personnel; vaccine surveillance reports lower uptake rates than the national average

Methods: Aims were 1) describe the HPV vaccination knowledge and socio-demographics 2) describe the relationship between HPV vaccination knowledge, HPV vaccine uptake, and socio-demographics and 3) identify select variables accounting for variance in HPV vaccine uptake among military personnel 18 to 26 years of age. The cross-sectional, correlational research design used an Internet-delivered survey which included a 13-item scale on HPV vaccination knowledge. Participants were Active Duty or Reservists stationed in San Diego, California. Descriptive and inferential statistics were used to analyze the results.

Results: There were 223 respondents: median age of 22 (IQR = 3); the majority was white (53.9%) and single (32.8%). Overall 41.2% (n = 96) had received at least one dose of the HPV vaccine and of those participants who initiated the HPV vaccine, 40% (n = 38) completed the series. Participants had a median score of 6 (range = 12) on the 13-item HPV knowledge scale. The highest item answered correctly was HPV vaccine recommended for all females 11 – 26 years of age (64.4% correct, n = 150) and the lowest item was both HPV vaccines protect against both genital warts and cervical cancer (12.5 correct, n = 29). Factors that significantly increased the odds of HPV vaccine included participants’ belief that their chain of command strongly agrees (OR = 14.34) or agrees (OR = 11.1); gender (OR = 4.52); learned about the vaccine from providers, media (OR = 0.17), or the Internet (OR = 0.10); and HPV vaccine knowledge scores (OR = 1.46) (p < 0.05).

Conclusions: The results of this study will enhance existing knowledge within military research by allowing health care professionals and policy makers to further understand the content needed to develop effective HPV immunization programs and policies. The results will assist in the eliminating barriers to the HPV vaccine among this high-risk group by increasing awareness of HPV and the HPV vaccine.

Disclosures: The Uniformed Services University (USU), 4301 Jones Bridge Road, Bethesda, MD 20814-4799, is the awarding and administering office (Award Number: N15-011). This project is partially sponsored by the TriService Nursing Research Program (TSNRP), USU; however, the information or content and conclusion do not necessarily represent the official position or policy of, nor should any official endorsements be inferred by, the TSNRP, the USU, the Department of Defense, or the U.S. Government.